![Bryan Dulhunty](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bryan Dulhunty
Corporate Secretary at ANALYTICA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jerel Banks | M | 49 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 8 years |
Peter Francis | M | 68 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 18 years |
Megan Boston | F | 52 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 8 years |
J. Buchi | M | 69 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 11 years |
Ross Mangelsdorf | M | - | 16 years | |
Kerrie Boyd | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 years |
Peter Corr | M | 76 | 7 years | |
Edward Smith | M | 53 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 4 years |
Michael Monsour | M | - | 20 years | |
Oliver Kidd | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 years |
Chelsea Cornelius | F | - | 16 years | |
Megan Henken | F | - | - | |
Peter Roelvink | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 9 years |
Maria Kavallaris | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gregory West | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 years |
Peter Laurence Molloy | M | 70 | 6 years | |
Iain Ross | M | 71 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 years |
John Chiplin | M | 66 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 7 years |
Paul Hopper | M | 68 | 10 years | |
Phillip Altman | M | - | 7 years | |
Leonard Post | M | 72 | - | |
Geoff Daly | M | - | 18 years | |
Georgina H. Kilfoil | F | 55 |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 4 years |
Gina Bozinovski | F | - | 1 years | |
Sakura Holloway | F | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | - |
David Suhy | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 6 years |
Tom Rowe | M | - | 1 years | |
Thomas Lönngren | M | 73 | 5 years | |
Jennie Yuen | F | - | - | |
Wolfgang Hanisch | M | - | - | |
Stephen Goodall | M | - | 3 years | |
Carl Stubbings | M | - | 4 years | |
Nadaisan Logaraj | M | 75 | - | |
Thomas Rowe | M | - | 1 years | |
Warren Stephen Brooks | M | - | 6 years | |
Cliff Holloway | M | - |
Benitec Biopharma Ltd.
![]() Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | 2 years |
Dennis J. Feeney | M | - | - | |
Steve P. Jones | M | - | - | |
Natalie Duve | F | - | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
Australia | 39 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bryan Dulhunty
- Personal Network